USC Stem Cell scientist Justin Ichida has learned to inhabit two worlds: the university where his lab makes discoveries, and the companies that can help commercialize these discoveries into new treatments for neurodegenerative diseases. The first of these potential treatments now has the potential to enter clinical development for patients with amyotrophic lateral sclerosis (ALS),…Continue Reading Research from Justin Ichida’s lab advances toward clinical development for ALS, following a license agreement between companies Takeda and AcuraStem
